Maetzold Derek J's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Aug 7, 2023
- Accession no.
- 0001447362-23-000130
- Filed
- Aug 7, 2023
- Trade date
- Aug 3, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions. Open-market sales total $12.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maetzold Derek JCIK 0001239501 | Director, Officer (Pres. & Chief Exec. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2023 | Common Stock | SSaleDisposed | −286 | $20.10F2 | −$5,748.6 | 121,527 | Direct | |
| Aug 3, 2023 | Common Stock | SSaleDisposed | −90 | $20.10F2 | −$1,809 | 107,880 | Indirect | |
| Aug 3, 2023 | Common Stock | SSaleDisposed | −90 | $20.10F2 | −$1,809 | 96,775 | Indirect | |
| Aug 3, 2023 | Common Stock | SSaleDisposed | −35 | $20.10F2 | −$703.5 | 17,395 | Indirect | |
| Aug 3, 2023 | Common Stock | SSaleDisposed | −33 | $20.10F2 | −$663.3 | 17,397 | Indirect | |
| Aug 3, 2023 | Common Stock | SSaleDisposed | −33 | $20.10F2 | −$663.3 | 17,397 | Indirect | |
| Aug 3, 2023 | Common Stock | SSaleDisposed | −33 | $20.10F2 | −$663.3 | 17,391 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $20.01 to $20.19, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.